Surgery and Prognostic Consideration in Differentiated Thyroid Cancer(DTC) |
Byun, Kyung-Do
(Department of Surgery, Busan Paik Hospital, Inje University College of Medicine)
Ha, Tae-Kwun (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) Ryu, Sung-Mock (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) Kim, Tae-Hyun (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) Kim, Sang-Hyo (Department of Surgery, Busan Paik Hospital, Inje University College of Medicine) |
1 | Korea Central Cancer Registry. 2002 Annual Report of the korea central cancer Registry;2003 |
2 | Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M. Cancer statistics, CA Cancer J Clin. 2007;57:43-66 DOI ScienceOn |
3 | Clark JR, Lai P, Hall F, Borglund A, Eski S, Freeman JL. Variables predicting distant metastases in thyroid cancer. Laryngoscope. 2005;115:661-667 DOI PUBMED ScienceOn |
4 | Ashok R, Shaha MD. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 2004;114:393-402 DOI PUBMED ScienceOn |
5 | Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Gaillon B. Microcarcinoma of the thyroid gland: The Gustar Roussy Institute experience. Cancer. 1998;83:553-559 DOI ScienceOn |
6 | Shah JP, Loree TR, Dharker DD, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658 DOI ScienceOn |
7 | Sobin LH, Wittekind C. Head and Neck Tumors. In: TNM classification of malignant tumors, sixth edition. John Wiley & Sons, New York. 2002:52-56 |
8 | Pellegriti G, Scolio C, Lumera G, Regalbuto C, Vigneri R. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5cm in diameter: Study of 299 cases. J Clin Endoclinol Metab. 2004;89:3713-3720 DOI ScienceOn |
9 | Hay ID, Grant CS, Varn Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery. 1992;112:1130-1147 PUBMED ScienceOn |
10 | Machens A. Hinze R, Thomusch O, Dralle H. Pattern of modal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22-28 DOI ScienceOn |
11 | Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501-511 DOI PUBMED ScienceOn |
12 | Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142 DOI ScienceOn |
13 | Hay ID, Grant CS, Taylor WF, McConahy WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary carcinoma: A retrospective analysis surgery of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088-1095 PUBMED |
14 | Sosa Ja, Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol. 2006;94(8):701-707 DOI ScienceOn |
15 | McConahey WM, Hay ID, Woolner LB, Van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manefestations, pathologic findings, theraphy and outcome. Mayo clin proc. 1986;61:978-996 DOI PUBMED ScienceOn |
16 | Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12(1):81-89 DOI ScienceOn |
17 | Caron NR, Clark OH. Papillary thyroid cancer.surgical management of lymph node meatastasis. Curr Treat Options Oncol. 2005; 6:311-322 DOI ScienceOn |
18 | Martin JS, Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med. 1998;338:297-306 DOI ScienceOn |
19 | Appetecchia M, Scarcello G, Pucci E, Procaccin A. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res. 2002;21(2):159-164 PUBMED |
20 | Cady B, Rossi R. An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953 PUBMED |
21 | DeGroot LJ, Kaplan EL, Mccormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424 DOI PUBMED |
22 | Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA. 2008;295:2164-2167 DOI ScienceOn |
23 | Pacini F, Schlumberger M, Dralle H, Elisei R, smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803 DOI ScienceOn |
24 | Chew MH, Chan G, Siddigui MMA, Tai BC, Sivanandan R, Soo LC, et al. Risk-Stratified Management of well-differentiated Thyroid cancers: A Review of Experience from a Single Institution, 1990-2003 World J Surg. 2008;32:386-394 DOI ScienceOn |
25 | Sakorafas GH, Sampains D, Safioleas M. Cervical lymph node dissection in papillary thyroid cancer: Current trends, persisting controversies, and unclarified uncertainties. Surg Oncol, 2009: 1-14 PUBMED |